SteelPeak Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.26M Buy
5,219
+874
+20% +$893K 0.16% 114
2026
Q1
$4M Buy
4,345
+12
+0.3% +$12.2K 0.12% 128
2025
Q4
$4.66M Sell
4,333
-1,857
-30% -$1.78M 0.15% 104
2025
Q3
$4.72M Buy
6,190
+232
+4% +$173K 0.16% 102
2025
Q2
$4.64M Buy
5,958
+697
+13% +$542K 0.18% 103
2025
Q1
$4.35M Sell
5,261
-310
-6% -$258K 0.18% 109
2024
Q4
$4.3M Sell
5,571
-142
-2% -$118K 0.17% 104
2024
Q3
$5.06M Sell
5,713
-18
-0.3% -$16.2K 0.22% 87
2024
Q2
$5.19M Buy
5,731
+2,037
+55% +$1.63M 0.24% 85
2024
Q1
$2.87M Buy
3,694
+492
+15% +$350K 0.14% 125
2023
Q4
$1.87M Buy
3,202
+72
+2% +$42K 0.11% 152
2023
Q3
$1.68M Sell
3,130
-4,515
-59% -$2.33M 0.11% 143
2023
Q2
$3.59M Sell
7,645
-104
-1% -$43.6K 0.21% 85
2023
Q1
$2.66M Buy
7,749
+2,600
+50% +$877K 0.18% 96
2022
Q4
$1.88M Buy
5,149
+1,972
+62% +$699K 0.14% 119
2022
Q3
$1.03M Sell
3,177
-291
-8% -$92.2K 0.08% 164
2022
Q2
$1.13M Buy
3,468
+234
+7% +$70.2K 0.08% 156
2022
Q1
$926K Buy
3,234
+564
+21% +$145K 0.05% 199
2021
Q4
$738K Sell
2,670
-555
-17% -$141K 0.04% 205
2021
Q3
$745K Buy
3,225
+778
+32% +$192K 0.05% 198
2021
Q2
$562K Sell
2,447
-9,677
-80% -$1.94M 0.04% 256
2021
Q1
$2.27M Buy
12,124
+5,936
+96% +$1.16M 0.18% 97
2020
Q4
$1.04M Buy
6,188
+2,323
+60% +$347K 0.1% 153
2020
Q3
$572K Sell
3,865
-3,192
-45% -$494K 0.06% 169
2020
Q2
$1.16M Buy
7,057
+2,255
+47% +$346K 0.15% 105
2020
Q1
$666K Buy
4,802
+739
+18% +$102K 0.11% 130
2019
Q4
$534K Buy
+4,063
New +$471K 0.07% 167

Other funds holding LLY

SteelPeak Wealth's LLY Position: Q2 2026 in Review

SteelPeak Wealth increased its Eli Lilly (LLY) stake by 20% in Q2 2026, buying an estimated $893K and bringing the position to 5,219 shares worth $6.26M. The position accounts for 0.16% of the portfolio, ranked #114.

SteelPeak Wealth first reported a position in LLY in Q4 2019 and has held it in 27 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • SteelPeak Wealth held 5,219 shares of Eli Lilly worth $6.26M as of Q2 2026.
  • SteelPeak Wealth bought 874 Eli Lilly shares in Q2 2026, an estimated $893K.
  • Eli Lilly made up 0.16% of SteelPeak Wealth's portfolio in Q2 2026, its #114 holding.
  • SteelPeak Wealth first reported a position in Eli Lilly in Q4 2019 and has held it in 27 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on SteelPeak Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.